APR 02, 2020 3:04 PM PDT

Transforming T Cells into Powerful Memory Cells That Target Cancer

WRITTEN BY: Kara Marker

New cancer treatments are now based on harnessing the power of the human body’s own immune cells to get the job done. The job? Specifically target cells overcome with cancer, eliminate them, and prevent cancer from spreading to more cells, tissues, and organs. A new cellular therapy follows such an approach, utilizing the power of T cell conversion to target cancer.

Cellular therapies are used to target cancer, and the science behind these therapies is based on identifying specific T cells, extracting them from the host, treating them in the lab, expanding the cells in the lab, and returning them to the host for a desired, anti-cancer effect. The specific T cell type that results from such therapies is usually effector CD8-positive T cells. A successful cellular therapy will create such T cells fully equipped to target specific tumor cells based on cell-surface antigens.

The new therapy’s main goal is to transform effector T cells into a strong hive of memory T cells. Why memory T cells? This population of immune cells has a proclivity toward growth. They are durable and “capable of self-renewal.” They are also able to trigger the targeting of cells for destruction, such as cancerous cells.

“What they see, they kill very well,” explained senior author Cassian Yee, MD.

Yee’s team is also focused on supporting memory T cell growth because this cell type is persistent, and without a tenacious population of T cells, cellular therapies often do not achieve success.

After identifying and extracting T cells from a host, Yee’s team treated the cells with a combination of:

  1. An epigenetic drug, panobinostat
  2. A cytokine, interleukin (IL)-21

IL-21 activates STAT3, a protein required for the interaction between T cell stimulatory protein CD28 and its genetic promoter region. Without the IL-21 treatment, histone proteins inhibit this interaction, preventing CD28 activation. CD28 is a protein expressed on the surface of T cells that plays an important role in T cell activation and survival.

Before Yee’s team treated extracted T cells with panobinostat, they used a different drug called vorinostat. However, pabinostat is less toxic and more effective at producing memory T cells. In addition to the treatment, researchers expanded the T cell populations in the lab.

Yee’s team’s work on the new cellular therapy joins a group of similar therapies that rely on expanding T cells in the lab before returning them to the host:

  • Chimeric antigen receptor T cells genetically modified to attack a specific target and used to treat B cell blood cancers
  • Leukocytes extracted from tumors to treat melanoma
  • Endogenous T cells transformed into super powered T cells equipped to attack tumor cells in the blood

Sources: University of Texas M.D. Anderson Cancer Center, Cancer Immunology Research, Immunity

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 28, 2020
Genetics & Genomics
Why Some Young, Healthy People Get Severe COVID-19
SEP 28, 2020
Why Some Young, Healthy People Get Severe COVID-19
Since the start of the pandemic, scientists have been trying to find out why some people get such severe illness from SA ...
DEC 03, 2020
Immunology
Cytokine Storms Aren't to Blame for COVID Respiratory Failures
DEC 03, 2020
Cytokine Storms Aren't to Blame for COVID Respiratory Failures
Many of the life-threatening symptoms of COVID-19 have been pinned on “cytokine storms” — immune syste ...
DEC 13, 2020
Cell & Molecular Biology
The Immune Response to Infection and Vaccination Depends on Previous Infections
DEC 13, 2020
The Immune Response to Infection and Vaccination Depends on Previous Infections
After we are exposed to a pathogen or in the case of vaccines, a portion of a pathogen, our body mounts an immune respon ...
DEC 14, 2020
Genetics & Genomics
tRNA Plays a Role in the Immune Response to Stroke
DEC 14, 2020
tRNA Plays a Role in the Immune Response to Stroke
At one time, researchers knew that various forms of RNA served a few different critical roles in the creation of protein ...
DEC 20, 2020
Microbiology
How Do mRNA Vaccines Work?
DEC 20, 2020
How Do mRNA Vaccines Work?
Scientist Katalin Karikó studied mRNA vaccines for years. She spent years getting grant rejections, but has now helped c ...
JAN 20, 2021
Immunology
Gut Bacteria's Poison Arrows Exposed
JAN 20, 2021
Gut Bacteria's Poison Arrows Exposed
Bacteria armed with toxin bombs and excruciating abdominal pains caused by raging inflammation in the gut. While the cau ...
Loading Comments...